CLDX Related Analyst PT Change
-
Jefferies Boosts PT on Celldex Therapeutics (CLDX) to $15
-
Oppenheimer Lifts Target on Celldex Therapeutics (CLDX) on Final Phase IIb CDX-011 Data
-
Jefferies Lifts Target on Celldex Therapeutics (CLDX) to $9 on Compelling CDX-011 OS Data
-
Oppenheimer Lifts Target on Celldex Therapeutics (CLDX) on CDX-011 Potential
Back to CLDX Stock Lookup
